![]() |
||||
|
||||
|
|
||||
Re: Bisphosphonates and osteonecrosis - from an OMFSFrom: Joanne Bulley, MD (islesannie@yahoo.com)Mon Jun 5 17:57:41 2006
I never quit. I just don't promote it. I present it as one of the options (and the only one that REALLY works for vasomotor symptoms and vaginal sexual function). So I present the pros and cons. It does confirm my interest in Evista along with Calcium and Vitamin D and Exercise until reachin that T score of -2.5. The major risk with HT is to the woman whose body has not had estrogen for 10-20 years and it is started de novo. (And this use was for the WHI study only as none of us in the trenches would have started a 60-79 yo woman without vasomotor symptoms on it.) So for the symptoms for the early menopausal / perimenopausal nothing else works as well. When the bisphosphonates were first being promoted (by the drug reps - by endocrinologists and rheumatologists) I would ask the question, "if this drug has been studied for roughly 5 years, are you serious about me potentially prescribing it for 20, 30, 40 years? What evidence do you have for me regarding long term use?" I never got any good answers. Anybody using Forteo? Joanne
At Mon, 5 Jun 2006, art fougner, md wrote:
>
-- Joanne Bulley, MD Keene, NH, USA
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Jul 2 04:44:06 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.